日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Repeated positron emission tomography tracing neutrophil elastase in a porcine intensive-care sepsis model

在猪重症监护脓毒症模型中重复进行正电子发射断层扫描追踪中性粒细胞弹性蛋白酶

Wilske, Frida; Eriksson, Olof; Amini, Rose-Marie; Estrada, Sergio; Janols, Helena; Khalil, Amina; Larsson, Anders; Lipcsey, Miklós; Mangsbo, Sara; Sigfridsson, Jonathan; Sjölin, Jan; Skorup, Paul; Wall, Anders; Wilson, Viola; Castegren, Markus; Antoni, Gunnar

Blood Levels of Dendritic Cell Populations in Patients with Moderate to Severe Traumatic Brain Injury

中重度创伤性脑损伤患者血液中树突状细胞数量的水平

Fridh, Patrik; Katsler, Ebba; Marklund, Niklas; Mangsbo, Sara; Ebendal, Ted

Correlates of protection and viral load trajectories in omicron breakthrough infections in triple vaccinated healthcare workers

接种过三重疫苗的医护人员中,奥密克戎病毒突破性感染的保护相关性及病毒载量轨迹

Marking, Ulrika; Havervall, Sebastian; Norin, Nina Greilert; Bladh, Oscar; Christ, Wanda; Gordon, Max; Ng, Henry; Blom, Kim; Phillipson, Mia; Mangsbo, Sara; Alm, Jessica J; Smed-Sörensen, Anna; Nilsson, Peter; Hober, Sophia; Åberg, Mikael; Klingström, Jonas; Thålin, Charlotte

Elevated levels of MMP12 sourced from macrophages are associated with poor prognosis in urothelial bladder cancer

巨噬细胞来源的MMP12水平升高与尿路上皮膀胱癌预后不良相关。

Kerzeli, Iliana K; Kostakis, Alexandros; Türker, Polat; Malmström, Per-Uno; Hemdan, Tammer; Mezheyeuski, Artur; Ward, Douglas G; Bryan, Richard T; Segersten, Ulrika; Lord, Martin; Mangsbo, Sara M

Factors Associated With Serological Response to SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Treated With Rituximab

利妥昔单抗治疗的多发性硬化症患者接种SARS-CoV-2疫苗后血清学反应的相关因素

Tolf, Andreas; Wiberg, Anna; Müller, Malin; Nazir, Faisal Hayat; Pavlovic, Ivan; Laurén, Ida; Mangsbo, Sara; Burman, Joachim

Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID-19

无症状或轻症新冠肺炎患者在感染后至少 8 个月内,体液和细胞免疫反应强劲,再次感染风险较低。

Havervall, Sebastian; Ng, Henry; Jernbom Falk, August; Greilert-Norin, Nina; Månberg, Anna; Marking, Ulrika; Laurén, Ida; Gabrielsson, Lena; Salomonsson, Ann-Christin; Aguilera, Katherina; Kihlgren, Martha; Månsson, Maja; Rosell, Axel; Hellström, Cecilia; Andersson, Eni; Olofsson, Jennie; Skoglund, Lovisa; Yousef, Jamil; Pin, Elisa; Lord, Martin; Åberg, Mikael; Hedhammar, My; Tegel, Hanna; Dönnes, Pierre; Phillipson, Mia; Nilsson, Peter; Klingström, Jonas; Mangsbo, Sara; Hober, Sophia; Thålin, Charlotte

Impact of SARS-CoV-2 infection on vaccine-induced immune responses over time

SARS-CoV-2感染对疫苗诱导的免疫反应随时间变化的影响

Havervall, Sebastian; Marking, Ulrika; Greilert-Norin, Nina; Gordon, Max; Ng, Henry; Christ, Wanda; Phillipson, Mia; Nilsson, Peter; Hober, Sophia; Blom, Kim; Klingström, Jonas; Mangsbo, Sara; Åberg, Mikael; Thålin, Charlotte

Duration of SARS-CoV-2 Immune Responses Up to Six Months Following Homologous or Heterologous Primary Immunization with ChAdOx1 nCoV-19 and BNT162b2 mRNA Vaccines.

使用 ChAdOx1 nCoV-19 和 BNT162b2 mRNA 疫苗进行同源或异源初次免疫后,SARS-CoV-2 免疫反应的持续时间可达六个月

Marking Ulrika, Havervall Sebastian, Greilert-Norin Nina, Ng Henry, Blom Kim, Nilsson Peter, Phillipson Mia, Hober Sophia, Nilsson Charlotta, Mangsbo Sara, Christ Wanda, Klingström Jonas, Gordon Max, à berg Mikael, Thålin Charlotte

SARS-CoV-2 induces a durable and antigen specific humoral immunity after asymptomatic to mild COVID-19 infection

SARS-CoV-2 在无症状或轻症 COVID-19 感染后可诱导持久的、抗原特异性的体液免疫。

Havervall, Sebastian; Jernbom Falk, August; Klingström, Jonas; Ng, Henry; Greilert-Norin, Nina; Gabrielsson, Lena; Salomonsson, Ann-Christin; Isaksson, Eva; Rudberg, Ann-Sofie; Hellström, Cecilia; Andersson, Eni; Olofsson, Jennie; Skoglund, Lovisa; Yousef, Jamil; Pin, Elisa; Christ, Wanda; Olausson, Mikaela; Hedhammar, My; Tegel, Hanna; Mangsbo, Sara; Phillipson, Mia; Månberg, Anna; Hober, Sophia; Nilsson, Peter; Thålin, Charlotte

Telomerase as a Target for Therapeutic Cancer Vaccines and Considerations for Optimizing Their Clinical Potential

端粒酶作为癌症治疗疫苗的靶点及其优化临床应用潜力的考量

Ellingsen, Espen Basmo; Mangsbo, Sara M; Hovig, Eivind; Gaudernack, Gustav